Total Payments
$131,586
2023 Payments
$125.00
Companies
31
Transactions
591
Medicare Patients
2,264
Medicare Billing
$121,821
Payment Breakdown by Category
Other$78,963 (60.0%)
Consulting$33,009 (25.1%)
Food & Beverage$12,100 (9.2%)
Travel$7,377 (5.6%)
Education$136.68 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $78,963 | 34 | 60.0% |
| Consulting Fee | $33,009 | 8 | 25.1% |
| Food and Beverage | $12,100 | 498 | 9.2% |
| Travel and Lodging | $7,377 | 46 | 5.6% |
| Education | $136.68 | 5 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $63,394 | 168 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $38,187 | 62 | $0 (2022) |
| GENZYME CORPORATION | $18,832 | 30 | $0 (2021) |
| Genentech USA, Inc. | $5,016 | 36 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $2,315 | 95 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $955.11 | 42 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $625.15 | 46 | $0 (2020) |
| Insmed, Inc. | $370.45 | 14 | $0 (2021) |
| Mylan Specialty L.P. | $314.89 | 17 | $0 (2021) |
| Grifols USA, LLC | $217.11 | 10 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $125.00 | 1 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2022 | $1,004 | 6 | Regeneron Healthcare Solutions, Inc. ($792.91) |
| 2021 | $45,406 | 103 | Regeneron Healthcare Solutions, Inc. ($17,326) |
| 2020 | $6,870 | 86 | GlaxoSmithKline, LLC. ($3,563) |
| 2019 | $52,200 | 203 | GlaxoSmithKline, LLC. ($30,733) |
| 2018 | $25,129 | 146 | GlaxoSmithKline, LLC. ($12,536) |
| 2017 | $852.11 | 46 | GlaxoSmithKline, LLC. ($272.04) |
All Payment Transactions
591 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 11/28/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/17/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $66.32 | General |
| Category: Respiratory | ||||||
| 08/09/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $701.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/21/2022 | Vapotherm Inc | VAPOTHERM (Device) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: RESPIRATORY | ||||||
| 05/17/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $74.73 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/27/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.12 | General |
| Category: Respiratory | ||||||
| 12/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $311.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $41.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/07/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,059.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $72.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/30/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: RESPIRATORY | ||||||
| 11/23/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $676.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/16/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,736.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,059.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,030.00 | General |
| Category: Immunology | ||||||
| 11/11/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $165.96 | General |
| Category: Immunology | ||||||
| 11/11/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $128.15 | General |
| Category: Immunology | ||||||
| 11/10/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,736.00 | General |
| Category: Immunology | ||||||
| 11/10/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $214.46 | General |
| Category: Immunology | ||||||
| 11/10/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $128.15 | General |
| Category: Immunology | ||||||
| 11/10/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $89.67 | General |
| Category: Immunology | ||||||
| 10/30/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $194.40 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 10 | 1,085 | 1,264 | $130,279 | $56,294 |
| 2020 | 13 | 1,179 | 1,322 | $136,649 | $65,527 |
Total Patients
2,264
Total Services
2,586
Medicare Billing
$121,821
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 297 | 444 | $67,768 | $30,922 | 45.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 78 | 95 | $20,054 | $9,910 | 49.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 54 | 62 | $8,006 | $4,476 | 55.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 45 | 45 | $8,786 | $3,784 | 43.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 13 | $3,546 | $1,766 | 49.8% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 172 | 174 | $5,060 | $1,756 | 34.7% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 176 | 178 | $6,960 | $1,338 | 19.2% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2021 | 143 | 143 | $5,005 | $1,244 | 24.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 85 | 87 | $3,424 | $604.58 | 17.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 23 | $1,670 | $494.36 | 29.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 270 | 348 | $39,832 | $20,488 | 51.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 150 | 171 | $29,895 | $13,984 | 46.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 132 | 164 | $17,610 | $10,181 | 57.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 45 | 45 | $10,989 | $6,178 | 56.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 111 | 113 | $8,535 | $2,559 | 30.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 31 | 31 | $5,110 | $2,559 | 50.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 24 | 25 | $4,145 | $2,360 | 56.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 19 | 19 | $4,218 | $2,281 | 54.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 38 | 42 | $2,460 | $1,612 | 65.5% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2020 | 99 | 100 | $2,375 | $1,058 | 44.6% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Facility | 2020 | 82 | 82 | $3,720 | $902.16 | 24.3% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2020 | 110 | 112 | $4,400 | $858.24 | 19.5% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2020 | 56 | 58 | $2,100 | $411.26 | 19.6% |
| 94726 | Determination of lung volumes using plethysmography | Facility | 2020 | 12 | 12 | $1,260 | $94.32 | 7.5% |
About Dr. Albert Driver, MD
Dr. Albert Driver, MD is a Pulmonary Disease healthcare provider based in Sellersville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811973803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Driver, MD has received a total of $131,586 in payments from pharmaceutical and medical device companies, with $125.00 received in 2023. These payments were reported across 591 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($78,963).
As a Medicare-enrolled provider, Driver has provided services to 2,264 Medicare beneficiaries, totaling 2,586 services with total Medicare billing of $121,821. Data is available for 2 years (2020–2021), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Allergy & Immunology
- Location Sellersville, PA
- Active Since 12/21/2005
- Last Updated 03/27/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1811973803
Products in Payments
- DUPIXENT (Biological) $42,558
- TRELEGY ELLIPTA (Drug) $32,337
- NUCALA (Biological) $10,917
- DUPIXENT (Drug) $9,683
- ANORO (Drug) $7,816
- Xolair (Biological) $4,928
- DUPIXENT DUPILUMAB INJECTION (Biological) $4,778
- BREZTRI (Drug) $586.22
- SYMBICORT (Drug) $579.55
- FASENRA (Drug) $562.70
- STIOLTO RESPIMAT (Drug) $391.93
- Arikayce (Drug) $370.45
- LONHALA MAGNAIR (Drug) $369.38
- BEVESPI AEROSPHERE (Drug) $270.38
- Yupelri (Drug) $236.60
- Prolastin-C Liquid (Biological) $177.06
- GLASSIA (Biological) $151.72
- TUDORZA PRESSAIR (Drug) $145.84
- SPIRIVA RESPIMAT (Drug) $143.06
- XOLAIR (Biological) $137.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.